MedPath

AcrySof IQ Toric A-Code Post-Market Clinical Study

Not Applicable
Completed
Conditions
Cataract
Astigmatism
Interventions
Device: AcrySof IQ Toric A-code IOL
Procedure: Cataract surgery
Registration Number
NCT03350503
Lead Sponsor
Alcon Research
Brief Summary

The purpose of this study is to clinically confirm the rotational stability of a modified AcrySof IQ toric intraocular lens (IOL) in a Japanese population.

Detailed Description

Patients will be examined pre-operatively to up to 3 years post-operatively. One eligible eye will be selected as a target eye for efficacy analysis. If both eyes are eligible, the eye in which the IOL is implanted first will be selected as the target eye.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
125
Inclusion Criteria
  • Diagnosis of cataracts with planned cataract removal by phacoemulsification
  • Calculated lens power within the available range
  • Able to sign informed consent and complete all study visits
  • Other protocol-defined inclusion criteria may apply.
Exclusion Criteria
  • Eye conditions as specified in the protocol
  • Uncontrolled glaucoma
  • Pregnancy, current or planned
  • Other protocol-defined exclusion criteria may apply.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Acrysof IQ Toric A-code IOLAcrySof IQ Toric A-code IOLIOL implanted during cataract surgery
Acrysof IQ Toric A-code IOLCataract surgeryIOL implanted during cataract surgery
Primary Outcome Measures
NameTimeMethod
Percentage of Eyes With Absolute Value of Intraocular (IOL) Rotation (Visit 00 to Visit 4)Visit 00 (Day 0 operative), Visit 4 (Day 120-180 postoperative)

IOL rotation was defined as the IOL axis difference between study visits. A photograph of the eye was taken, and IOL rotation was calculated as the angle between the toric mark on the IOL at Visit 4 and the reference point from Visit 00 (minimum 0 degrees, maximum 180 degrees). A lower value indicates greater IOL stability. No confirmatory hypothesis testing was conducted.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Alcon Investigative Site

🇯🇵

Saga, Saga Prefecture, Japan

© Copyright 2025. All Rights Reserved by MedPath